Clinical Trial Update: CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CM4620 Injectable Emulsion versus supportive care in patients with acute pancreatitis and systemic inflammatory response syndrome; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• CM4620 Injectable Emulsion (CM4620)

Snippet

Sponsor: CalciMedica, Inc. | Conditions: Acute Pancreatitis, Systemic Inflammatory Response Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-12-07